JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

JNJ

192.2

-0.47%↓

ABT

127.06

-1.1%↓

MDT

93.96

-2.69%↓

VEEV

289

-0.19%↓

A

146.19

+0.72%↑

Search

Harmony Biosciences Holdings Inc

Open

SectorGezondheidszorg

28.92 10.09

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

26.1

Max

29.24

Belangrijke statistieken

By Trading Economics

Inkomsten

-5.8M

40M

Verkoop

16M

200M

K/W

Sectorgemiddelde

8.367

37.461

EPS

0.92

Winstmarge

19.839

Werknemers

268

EBITDA

3M

59M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+70.34% upside

Dividenden

By Dow Jones

Volgende Winsten

28 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-544M

1.5B

Vorige openingsprijs

18.83

Vorige sluitingsprijs

28.92

Nieuwssentiment

By Acuity

34%

66%

108 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

Harmony Biosciences Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 okt 2025, 22:47 UTC

Acquisities, Fusies, Overnames

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22 okt 2025, 22:13 UTC

Acquisities, Fusies, Overnames

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22 okt 2025, 21:20 UTC

Winsten

Correction to IBM 3Q Sales Jump Article

22 okt 2025, 20:57 UTC

Winsten

SAP Posts Higher 3Q Revenue, Operating Profit

22 okt 2025, 23:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

22 okt 2025, 23:46 UTC

Marktinformatie

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22 okt 2025, 23:41 UTC

Marktinformatie

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 okt 2025, 23:38 UTC

Marktinformatie

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22 okt 2025, 23:15 UTC

Winsten

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22 okt 2025, 22:28 UTC

Marktinformatie

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22 okt 2025, 22:02 UTC

Winsten

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22 okt 2025, 21:59 UTC

Acquisities, Fusies, Overnames

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22 okt 2025, 21:58 UTC

Acquisities, Fusies, Overnames

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22 okt 2025, 21:57 UTC

Acquisities, Fusies, Overnames

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22 okt 2025, 21:56 UTC

Acquisities, Fusies, Overnames

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22 okt 2025, 21:47 UTC

Acquisities, Fusies, Overnames

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22 okt 2025, 21:47 UTC

Winsten

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 okt 2025, 21:47 UTC

Acquisities, Fusies, Overnames

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22 okt 2025, 21:46 UTC

Acquisities, Fusies, Overnames

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22 okt 2025, 21:45 UTC

Acquisities, Fusies, Overnames

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22 okt 2025, 21:45 UTC

Acquisities, Fusies, Overnames

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22 okt 2025, 21:28 UTC

Marktinformatie
Winsten

Correction to Alcoa Tariff Market Talk

22 okt 2025, 21:25 UTC

Winsten

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22 okt 2025, 21:17 UTC

Winsten

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22 okt 2025, 21:09 UTC

Marktinformatie
Winsten

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22 okt 2025, 21:00 UTC

Marktinformatie

ESG Roundup: Market Talk

22 okt 2025, 20:59 UTC

Winsten

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22 okt 2025, 20:51 UTC

Winsten

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22 okt 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

22 okt 2025, 20:44 UTC

Winsten

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Peer Vergelijking

Prijswijziging

Harmony Biosciences Holdings Inc Prognose

Koersdoel

By TipRanks

70.34% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 44.56 USD  70.34%

Hoogste 62 USD

Laagste 31 USD

Gebaseerd op 10 Wall Street-analisten die 12-maands prijsdoelen bieden voor Harmony Biosciences Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

10 ratings

9

Buy

0

Hold

1

Sell

Technische score

By Trading Central

29.8 / N/ASteun & Weerstand

Korte Termijn

Weak Bullish Evidence

Gemiddeld Termijn

Weak Bullish Evidence

Lange Termijn

Very Strong Bearish Evidence

Sentiment

By Acuity

108 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.
help-icon Live chat